Search research articles
Contact Us
Filters
Showing results (1-10 of 147) with videos related to
Page
of 15
Sort By:
The Journal of Pathology
|
October 10, 2013
Developing biomarkers to predict benefit from HGF/MET pathway inhibitors
Hartmut Koeppen, Sandra Rost, Robert L Yauch
The Journal of Pathology
|
April 13, 2021
Microenvironmental regulation of tumour immunity and response to immunotherapy
Mark M Kockx, Mark McCleland, Hartmut Koeppen
Oncotarget
|
June 17, 2014
HGF/MET-directed therapeutics in gastroesophageal cancer: a review of clinical and biomarker development
Stephen P Hack, Jean-Marie Bruey, Hartmut Koeppen
The Journal of Pathology
|
October 15, 2013
Pathology in drug discovery and development
Adrian M Jubb, Hartmut Koeppen, Jorge S Reis-Filho
Nature Reviews. Cancer
|
July 14, 2006
Predicting benefit from anti-angiogenic agents in malignancy
Adrian M Jubb, Adam J Oates, Scott Holden, et al.
The Journal of Pathology
|
June 7, 2021
Recent Advances in Pathology: the 2021 Annual Review Issue of The Journal of Pathology
C Simon Herrington, Richard Poulsom, Hartmut Koeppen, et al.
Experimental Cell Research
|
April 24, 2002
MAGI-1: a widely expressed, alternatively spliced tight junction protein
Richard P Laura, Sarajane Ross, Hartmut Koeppen, et al.
Cancer Research
|
March 5, 2003
Selective cyclin-dependent kinase 2/cyclin A antagonists that differ from ATP site inhibitors block tumor growth
Nerissa Mendoza, Sharon Fong, Jim Marsters, et al.
Cell Death and Differentiation
|
July 9, 2026
Epithelial cancer cells co-opt the death ligand TRAIL to avert extrinsic apoptosis while acquiring killing capacity
John Canty, Scot Marsters, David Lawrence, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
September 30, 2017
Multiplexed ion beam imaging analysis for quantitation of protein expresssion in cancer tissue sections
Sandra Rost, Jennifer Giltnane, Jennifer M Bordeaux, et al.
Page
of 15
Search research articles
Search
Showing results (1-10 of 147) with videos related to
Sort By:
Page
of 15
The Journal of Pathology
|
October 10, 2013
Developing biomarkers to predict benefit from HGF/MET pathway inhibitors
Hartmut Koeppen, Sandra Rost, Robert L Yauch
The Journal of Pathology
|
April 13, 2021
Microenvironmental regulation of tumour immunity and response to immunotherapy
Mark M Kockx, Mark McCleland, Hartmut Koeppen
Oncotarget
|
June 17, 2014
HGF/MET-directed therapeutics in gastroesophageal cancer: a review of clinical and biomarker development
Stephen P Hack, Jean-Marie Bruey, Hartmut Koeppen
The Journal of Pathology
|
October 15, 2013
Pathology in drug discovery and development
Adrian M Jubb, Hartmut Koeppen, Jorge S Reis-Filho
Nature Reviews. Cancer
|
July 14, 2006
Predicting benefit from anti-angiogenic agents in malignancy
Adrian M Jubb, Adam J Oates, Scott Holden, et al.
The Journal of Pathology
|
June 7, 2021
Recent Advances in Pathology: the 2021 Annual Review Issue of The Journal of Pathology
C Simon Herrington, Richard Poulsom, Hartmut Koeppen, et al.
Experimental Cell Research
|
April 24, 2002
MAGI-1: a widely expressed, alternatively spliced tight junction protein
Richard P Laura, Sarajane Ross, Hartmut Koeppen, et al.
Cancer Research
|
March 5, 2003
Selective cyclin-dependent kinase 2/cyclin A antagonists that differ from ATP site inhibitors block tumor growth
Nerissa Mendoza, Sharon Fong, Jim Marsters, et al.
Cell Death and Differentiation
|
July 9, 2026
Epithelial cancer cells co-opt the death ligand TRAIL to avert extrinsic apoptosis while acquiring killing capacity
John Canty, Scot Marsters, David Lawrence, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
September 30, 2017
Multiplexed ion beam imaging analysis for quantitation of protein expresssion in cancer tissue sections
Sandra Rost, Jennifer Giltnane, Jennifer M Bordeaux, et al.
Page
of 15